Aktiespot

Vcanbio Cell & Gene Engineering Corp., Ltd (VCANBIO CELL & GENE ENG CORP LT) aktie

600645.SS

Fördröjd 15 min
¥18.80-1.03 (-5.19%)
Laddar diagram...

VCANBIO CELL & GENE ENG CORP LT

Öppning19.55
Högsta19.87
Lägsta18.80
Volym8.57M
P/E78.33
Börsvärde8.8B
52 veckors högsta32.99
52 veckors lägsta18.80
Genomsnittlig volym14.79M
UtdelningN/A
Beta-0.08
EPS0.24

Om Vcanbio Cell & Gene Engineering Corp., Ltd (VCANBIO CELL & GENE ENG CORP LT) aktie

Vcanbio Cell & Gene Engineering Corp., Ltd, together with its subsidiaries, engages in the preparation and storage of cell detection tests in the People's Republic of China. It offers cell test preparation and storage services for umbilical cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, immune cells, adipose stem cells, and dental stem cells. The company also provides genetic testing services related to non-invasive prenatal genetic testing during pregnancy, genetic testing for drug safety guidance, disease genetic testing, and disease susceptibility testing for children and adults; and in vitro diagnostic raw materials, such as monoclonal antibodies and polyclonal antibody products. In addition, it is involved in the research, development, production, and sales of biological genes, proteins, antibodies, pharmaceutical intermediates, and synthetic agents; and in vitro diagnostic reagents and medical devices. The company was founded in 1992 and is based in Tianjin, the People's Republic of China.

Företagsinformation

Börs: Shanghai (SHH)
Sektor: Sundhed
Industri: Bioteknologi
Adress:
Huayuan Industrial Zone
300384 Tianjin, China
Telefon: + 86 22 5877 5766

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Lägsta kursmål
Genomsnittligt kursmål
Median kursmål
Högsta kursmål

Andra tittar också på: